Thomas Beyer

1.5k citations

28 papers · 1.3k indexed · h-index 18

Impact in

Immunology top 5%
- Phagocytosis and Immune Regulation
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
Radiology, Nuclear Medicine and Imaging top 5%
- Monoclonal and Polyclonal Antibodies Research

Papers in

Immunology 18
- Phagocytosis and Immune Regulation 7
- T-cell and B-cell Immunology 6
- Immunotherapy and Immune Responses 5
Radiology, Nuclear Medicine and Imaging 13
- Monoclonal and Polyclonal Antibodies Research 13

Co-authors: Martin Herrmann Thomas Valerius Matthias Peipp Michael Dechant Reinhard Voll Jan G. J. van de Winkel Tanja Schneider‐Merck Udo S. Gaipl
Journals: The Journal of Immunology (5 papers)Journal of Clinical Oncology (4 papers)Blood (2 papers)Cell Death and Differentiation (2 papers)Cytometry Part A (1 paper)
Partner nations: Germany Netherlands United States

In The Last Decade

Thomas Beyer

27 papers receiving 1.2k citations

Peers

Countries citing papers authored by Thomas Beyer

Since Specialization

Citations

This map shows the geographic impact of Thomas Beyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Beyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Beyer more than expected).

Fields of papers citing papers by Thomas Beyer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Beyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Beyer. The network helps show where Thomas Beyer may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Thomas Beyer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Thomas Beyer Line = papers co-authored together Thomas Beyer links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Effect of a tail piece cysteine deletion on biochemical and functional properties of an epidermal growth factor receptor-directed IgA2 m(1) antibody mAbs ·Aoife Crowe, Stefan Lohse, Stefanie Derer, Matthias Peipp, Péter Boross, Christian Kellner, Thomas Beyer, Michael Dechant, Louise Royle, Li Phing Liew, Jeanette H.W. Leusen, Thomas Valerius	2013	17
2	Human IgG2 Antibodies against Epidermal Growth Factor Receptor Effectively Trigger Antibody-Dependent Cellular Cytotoxicity but, in Contrast to IgG1, Only by Cells of Myeloid Lineage The Journal of Immunology ·Tanja Schneider‐Merck, Jeroen J. Lammerts van Bueren, Sven Berger, 昌行柳沢, Patrick H.C. van Berkel, Stefanie Derer, Thomas Beyer, Stefan Lohse, Wim K. Bleeker, Matthias Peipp, Paul W.H.I. Parren, Jan G. J. van de Winkel, Thomas Valerius, Michael Dechant	2009	167
3	Serum-free production and purification of chimeric IgA antibodies Journal of Immunological Methods ·Thomas Beyer, Stefan Lohse, Sven Berger, Matthias Peipp, Thomas Valerius, Michael Dechant	2009	41
4	Complement-Dependent Tumor Cell Lysis Triggered by Combinations of Epidermal Growth Factor Receptor Antibodies Cancer Research ·Michael Dechant, María del Mar Rivas Estepa, Sven Berger, Matthias Peipp, Thomas Beyer, Tanja Schneider‐Merck, Jeroen J. Lammerts van Bueren, Wim K. Bleeker, Paul W.H.I. Parren, Jan G. J. van de Winkel, Thomas Valerius	2008	132
5	Tumor Cell Killing Mechanisms of Epidermal Growth Factor Receptor (EGFR) Antibodies Are Not Affected by Lung Cancer-Associated EGFR Kinase Mutations The Journal of Immunology ·Matthias Peipp, Tanja Schneider‐Merck, Michael Dechant, Thomas Beyer, Jeroen J. Lammerts van Bueren, Wim K. Bleeker, Paul W.H.I. Parren, Jan G. J. van de Winkel, Thomas Valerius	2008	22
6	Effector Mechanisms of Recombinant IgA Antibodies against Epidermal Growth Factor Receptor The Journal of Immunology ·Michael Dechant, Thomas Beyer, Tanja Schneider‐Merck, María del Mar Rivas Estepa, Matthias Peipp, Jan G. J. van de Winkel, Thomas Valerius	2007	75
7	An optimized conditional suicide switch using doxycycline-dependent expression of human tBid Cancer Biology & Therapy ·Anja Knott, Rumata Agustina Panjaitan, Thomas Beyer, Judith Z. Drexler, Christian Berens, Martin Hermann, Wolfgang Hillen	2005	8
8	Cooperation between C1q and DNase I in the clearance of necrotic cell–derived chromatin Arthritis & Rheumatism ·Udo S. Gaipl, Thomas Beyer, Petra Heyder, Christine Müller-Botsch, Jean M. De Jong, Reinhard Voll, Joachim R. Kalden, Martin Herrmann	2004	100
9	A randomized phase I study of the humanized anti-epidermal growth factor receptor (EGFR) monoclonal antibody EMD 72000 in subjects with advanced gastrointestinal cancers Journal of Clinical Oncology ·Tanja Trarbach, Thomas Beyer, N. Schleucher, J. Stattaus, Stefan Müeller, Abdul Francisco Joaquim Nunes, J. Tillner, K. W. Schmid, S. Seeber, U. Vanhoefer	2004	11
10	A randomized phase I study of the humanized anti-epidermal growth factor receptor (EGFR) monoclonal antibody EMD 72000 in subjects with advanced gastrointestinal cancers Journal of Clinical Oncology ·Tanja Trarbach, Thomas Beyer, N. Schleucher, J. Stattaus, Stefan Müeller, Abdul Francisco Joaquim Nunes, J. Tillner, K. W. Schmid, S. Seeber, U. Vanhoefer	2004	4
11	Polymorphonuclear Granulocytes Induce Antibody-Dependent Apoptosis in Human Breast Cancer Cells The Journal of Immunology ·Bernhard Stockmeyer, Thomas Beyer, Winfried Neuhuber, Roland Repp, Joachim R. Kalden, Thomas Valerius, Martin Herrmann	2003	56
12	UV or X-Irradiation Increases the CytoplasmicAccumulation of Rhodamine 123 in VariousCancer Cell Lines Strahlentherapie und Onkologie ·Ingrid E. Dumitriu, H. Dhilleswara Rao, Thomas Beyer, Udo S. Gaipl, Joachim R. Kalden, Martin Herrmann	2003	2
13	Impaired clearance of apoptotic cells in systemic lupus erythematosus: Challenge of T and B cell tolerance Current Rheumatology Reports ·Christine Müller-Botsch, Thomas Beyer, Reinhard Voll, Joachim R. Kalden, Martin Herrmann	2003	23
14	Early detection of apoptosis by staining of acid‐treated apoptotic cells with FITC‐labeled lectin from Narcissus pseudonarcissus Cytometry Part A ·Petra Heyder, Udo S. Gaipl, Thomas Beyer, Reinhard Voll, Peter Kern, C. Stach, Joachim R. Kalden, Martin Herrmann	2003	34
15	Disposal of dying cells: A balancing act between infection and autoimmunity Arthritis & Rheumatism ·Udo S. Gaipl, Jürgen Brunner, Thomas Beyer, Reinhard Voll, Joachim R. Kalden, Martin Herrmann	2003	31
16	Apoptosis of the Teratocarcinoma Cell Line Tera‐1 Leads to the Cleavage of HERV‐K10^gag Proteins by Caspases and/or Granzyme B Scandinavian Journal of Immunology ·Thomas Beyer, Wasilis Kolowos, Ingrid E. Dumitriu, Reinhard Voll, Petra Heyder, Udo S. Gaipl, J. R. Kalden, Martin Herrmann	2002	5
17	Bacterial Carriers and Virus-Like-Particles as Antigen Delivery Devices: Role of Dendritic Cells in Antigen Presentation PubMed ·Thomas Beyer, Martin Herrmann, Christian O. A. Reiser, Wolf Bertling, Jürgen Heß	2001	34
18	Complement binding is an early feature of necrotic and a rather late event during apoptotic cell death Cell Death and Differentiation ·Udo S. Gaipl, Christine Müller-Botsch, Reinhard Voll, Thomas Beyer, Wasilis Kolowos, Petra Heyder, J. R. Kalden, Martin Herrmann	2001	137
19	CD4 positive peripheral T cells from patients with systemic lupus erythematosus (SLE) are clonally expanded Lupus ·Wasilis Kolowos, Udo S. Gaipl, Reinhard Voll, E. Tomasevicius, Johannes‐Peter Haas, Thomas Beyer, J. R. Kalden, Martin Herrmann	2001	19
20	Treatment with annexin V increases immunogenicity of apoptotic human T-cells in Balb/c mice Cell Death and Differentiation ·C. Stach, Javier Turnay, Reinhard Voll, P. M. Kern, Wasilis Kolowos, Thomas Beyer, J. R. Kalden, Martin Herrmann	2000	70

About Thomas Beyer

Thomas Beyer is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging, Biotechnology, Genetics and Oncology, having authored 28 papers that have together received 1.3k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (13 papers), Glycosylation and Glycoproteins Research (7 papers), Phagocytosis and Immune Regulation (7 papers), T-cell and B-cell Immunology (6 papers), Immunotherapy and Immune Responses (5 papers), Cell death mechanisms and regulation (4 papers), Erythrocyte Function and Pathophysiology (4 papers) and HER2/EGFR in Cancer Research (4 papers). The work is most often cited by research in Immunology (780 citations), Radiology, Nuclear Medicine and Imaging (498 citations), Oncology (309 citations), Rheumatology (124 citations) and Biotechnology (68 citations). Thomas Beyer has collaborated with scholars based in Germany, Netherlands and United States. Frequent co-authors include Martin Herrmann, Thomas Valerius, Matthias Peipp, Michael Dechant, Reinhard Voll, Jan G. J. van de Winkel, Tanja Schneider‐Merck, Udo S. Gaipl, Paul W.H.I. Parren and Jeroen J. Lammerts van Bueren. Their work appears in journals such as The Journal of Immunology, Journal of Clinical Oncology, Blood, Cell Death and Differentiation and Cytometry Part A.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact